Wong Russell, Sichmann Mariangela G de O, Sun James, Kim Alexis R, Bianchini Robert J, Hermanson Kevin D, Chabert Louis
Rejuvenation Dermatology, 5083, Windermere Blvd Unit 101, Edmonton, AB, T6W 0J5, Canada.
Unilever Research and Development, Sao Paulo, Brazil.
Dermatol Ther (Heidelb). 2025 May;15(5):1209-1225. doi: 10.1007/s13555-025-01399-x. Epub 2025 Apr 20.
Melanin, derived from tyrosine, plays a pivotal role in skin pigmentation through melanogenesis. Disruptions in this process lead to hyperpigmentation, a condition affecting skin tone and quality of life. Current treatments, including chemical peels, have limitations, highlighting the need for novel solutions. Here, we present an innovative peeling system, comprising a masque and moisturizer, formulated with a novel blend of acids, including azelaic acid (AZA) and tranexamic acid (TXA), alongside known brightening and penetration-enhancing agents for a comprehensive solution to target hyperpigmentation.
In vitro studies assessed the ability of the novel moisturizer to inhibit ultraviolet-A (UVA)-induced melanin accumulation in human melanocytes. In a single-center, controlled study, we assessed the efficacy of the peeling system in 33 healthy female participants aged 30-55 years with moderate-to-severe hyperpigmentation over a 6-week treatment period. Skin condition was assessed using clinical photography, 3D skin topography, and clinical expert evaluation (CEE) at baseline and 6 weeks post-treatment. Participants completed a self-evaluation questionnaire at 6 weeks post-treatment.
In vitro findings demonstrated a concentration-dependent inhibition of melanin accumulation by the novel moisturizer. In vivo, significant reductions in dark spot number, area, and perimeter were observed at week 6, along with improvements in skin homogeneity, contrast, and brightness. Skin tone and roughness parameters also improved significantly from baseline. These findings were supported by self-evaluation findings and improvements in CEE parameters.
These data provide evidence for the efficacy of the innovative peeling system in reducing the appearance of hyperpigmentation over a 6-week treatment regimen in females with healthy skin and moderate-to-severe hyperpigmentation. The inclusion of AZA and TXA within the peeling system, along with active brightening and penetration-enhancing ingredients, may have synergistically facilitated the observed improvements. This multifaceted approach may address hyperpigmentation at the source, contributing to overall improvements in the appearance of the skin.
黑色素由酪氨酸衍生而来,通过黑色素生成在皮肤色素沉着中起关键作用。这一过程的紊乱会导致色素沉着过度,这种情况会影响肤色和生活质量。包括化学换肤在内的现有治疗方法存在局限性,凸显了对新解决方案的需求。在此,我们展示了一种创新的换肤系统,它由面膜和保湿霜组成,配方中含有新型酸类混合物,包括壬二酸(AZA)和氨甲环酸(TXA),以及已知的提亮和促进渗透的成分,以提供一种针对色素沉着过度的综合解决方案。
体外研究评估了新型保湿霜抑制紫外线A(UVA)诱导的人黑素细胞中黑色素积累的能力。在一项单中心对照研究中,我们评估了该换肤系统对33名年龄在30至55岁、有中度至重度色素沉着过度的健康女性参与者在6周治疗期内的疗效。在基线和治疗后6周,使用临床摄影、三维皮肤地形图和临床专家评估(CEE)来评估皮肤状况。参与者在治疗后6周完成一份自我评估问卷。
体外研究结果表明,新型保湿霜对黑色素积累的抑制作用呈浓度依赖性。在体内,在第6周时观察到黑斑数量、面积和周长显著减少,同时皮肤均匀度、对比度和亮度也有所改善。肤色和粗糙度参数也较基线有显著改善。这些发现得到了自我评估结果和CEE参数改善的支持。
这些数据证明了这种创新的换肤系统在6周治疗方案中对皮肤健康且有中度至重度色素沉着过度的女性减少色素沉着过度外观的疗效。换肤系统中包含的AZA和TXA,以及活性提亮和促进渗透成分,可能协同促进了观察到的改善。这种多方面的方法可能从源头解决色素沉着过度问题,有助于整体改善皮肤外观。